Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Hyperangulert versus standard geometri laryngoskopblad-studie (ANGLE)

16. september 2026 oppdatert av: Jonathan Casey, Vanderbilt University Medical Center

The Hyperangulated versus Standard Geometry Laryngoscope Blade (ANGLE) Trial is a multi-center, non-blinded, parallel-group, randomized clinical trial evaluating the effect of use of a hyperangulated video laryngoscope blade versus use of a standard geometry video laryngoscope blade. Critically ill adults undergoing tracheal intubation in participating EDs and ICUs who meet eligibility criteria will be enrolled and randomly assigned in a 1:1 ratio to either intubation using a hyperangulated video laryngoscope blade or a standard geometry video laryngoscope blade. The primary outcome is the incidence of successful intubation on the first attempt. The secondary outcome is incidence of hypoxemia during the interval between induction and 2 minutes after tracheal intubation.

Studieoversikt

Detaljert beskrivelse

Clinicians frequently perform tracheal intubation of critically ill patients in the emergency department (ED) or intensive care unit (ICU). In 10-20% of emergency tracheal intubations, clinicians are unable to intubate the trachea on the first attempt, which increases the risk of complications during intubation. To intubate the trachea, clinicians use a device called a laryngoscope, which consists of a handle with an attached blade. Clinicians intubate by holding the laryngoscope handle and inserting the blade into the patient's mouth to (1) visualize the opening to the trachea (the larynx) and (2) create a pathway through which an endotracheal tube can be advanced through the oropharynx and larynx and into the trachea.

Video laryngoscopes use a camera embedded in the laryngoscope blade to transmit images of the airway to a screen that can be viewed in real time by the clinician to aid endotracheal tube placement. Video laryngoscopes have been shown to improve the ability of clinicians to view the larynx and increase the likelihood of successful intubation on the first attempt, compared to direct laryngoscopes, which do not have a camera or a screen. A recent multicenter randomized trial found that, among 1,417 adults undergoing tracheal intubation in an ED or ICU, the incidence of successful intubation on the first attempt was 85% with a video laryngoscope and 70% with a direct laryngoscope (absolute difference, 14.3; 95% CI, 9.9 to 18.7). Use of a video laryngoscope is now standard of care for tracheal intubation in many EDs and ICUs and is recommended in international guidelines.

Two types of laryngoscope blades are available for use with video laryngoscopes in clinical care. Standard geometry video laryngoscope blades were designed to approximate the shape of Macintosh direct laryngoscopes, the preferred tool before the advent of video laryngoscopy. When using a standard geometry laryngoscope blade, the clinician inserts the blade into the mouth, displaces the tongue, and lifts up and away from the operator to elevate the epiglottis and expose the vocal cords. Because this approach creates a direct line-of-site view of the vocal cords, the clinician may view the vocal cords directly (with the naked eye) or indirectly on the video screen. Creating this line-of-site view of the vocal cords with a standard angulation blade may require more effort than with a hyperangulated blade, but it creates a direct pathway for passage of an endotracheal tube through the mouth and into the trachea. Because use of a standard geometry laryngoscope blade includes creation of a direct pathway for passage of an endotracheal tube, some experts have hypothesized that use of a standard geometry laryngoscope blade could increase the incidence of successful intubation on the first attempt, compared to use of hyperangulated blades.

Hyperangulated video laryngoscope blades were designed to have a more acute angle that more closely matches the natural curvature of the airway, allowing a view of the vocal cords with less manipulation of the airway. Because use of a hyperangulated blade does not include creation of a direct, line-of-sight view of the vocal cords, it is only used for indirect laryngoscopy with a video laryngoscope. When using a hyperangulated video laryngoscope blade, the clinician inserts the hyperangulated blade into the mouth, displaces the tongue, and then gently tilts the blade to view the vocal cords. While use of a hyperangulated blade may make it easier to obtain a view of the vocal cords, the pathway for passage of an endotracheal tube through the mouth and into the trachea may be less direct than with a standard geometry video laryngoscope blade. Some experts have hypothesized that, by making it easier to obtain a view of the vocal cords, use of a hyperangulated video laryngoscope blade may increase the incidence of successful intubation on the first attempt, compared to use of a standard geometry video laryngoscope blade.

Two randomized controlled trials among adults intubated by anesthesiologists during elective tracheal intubation in the operating room reported different effects of use of a hyperangulated versus standard geometry video laryngoscope blade on the incidence of successful intubation on the first attempt. Köhl et al reported a 30% increase in the incidence of successful intubation on the first attempt with use of a hyperangulated video laryngoscope blade (97% vs 67%; p=0.002) in patients with anticipated difficult airways. In contrast, Zhang et al reported a non-significant increase in the incidence of successful intubation on the first attempt with use of a standard geometry video laryngoscope blade (79% vs 71%; p=0.26) in patients in cervical immobilization.

Emergency tracheal intubation in the ED and ICU differs significantly from elective tracheal intubation in the operating room. Patients are more likely to have difficult airway characteristics that might make it more challenging to obtain a complete view of the larynx (e.g., cervical spine immobilization during trauma), rates of failure on the first attempt and complications during intubation are significantly higher, and clinicians performing intubation have less prior experience performing intubation, on average. No prior randomized trials have compared hyperangulated blades to standard geometry blades during intubation using a video laryngoscope in the ED or ICU. To determine the effect of use of a hyperangulated video laryngoscope blade versus a standard geometry video laryngoscope blade on the incidence of successful intubation on the first attempt among critically ill adults undergoing intubation in the ED or ICU, a randomized trial is needed.

Studietype

Intervensjonell

Registrering (Antatt)

2500

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 37205
        • University of Alabama at Birmingham
    • California
      • Los Angeles, California, Forente stater, 90095
        • University of California, Los Angeles
      • Stanford, California, Forente stater, 94305
        • Stanford University
    • Colorado
      • Denver, Colorado, Forente stater, 80204
        • Denver Health Medical Center
      • Denver, Colorado, Forente stater, 80045
        • University of Colorado, Denver Anschutz Medical Campus
    • Illinois
      • Chicago, Illinois, Forente stater, 60612
        • Rush University Medical Center
    • Louisiana
      • Baton Rouge, Louisiana, Forente stater, 70808
        • Our Lady of the Lake Hospital, Inc.
      • Jefferson, Louisiana, Forente stater, 70121
        • Ochsner Clinic Foundation
      • New Orleans, Louisiana, Forente stater, 70112
        • Lsu/Umcno
    • Maryland
      • Baltimore, Maryland, Forente stater, 21201
        • University of Maryland Baltimore
    • Massachusetts
      • Burlington, Massachusetts, Forente stater, 01805
        • Lahey Clinic, Inc
    • Minnesota
      • Minneapolis, Minnesota, Forente stater, 55415
        • Hennepin Healthcare component - Hennepin County Medical Center
    • North Carolina
      • Durham, North Carolina, Forente stater, 27710
        • Duke University Medical Center
      • Winston-Salem, North Carolina, Forente stater, 27109
        • Wake Forest University Health Sciences
    • Ohio
      • Columbus, Ohio, Forente stater, 43210
        • The Ohio State University
    • Oregon
      • Portland, Oregon, Forente stater, 97239
        • Oregon Health & Science University
    • Tennessee
      • Nashville, Tennessee, Forente stater, 37232
        • Vanderbilt University Medical Center
    • Texas
      • Dallas, Texas, Forente stater, 75201
        • Baylor Scott & White Research Institute
    • Virginia
      • Norfolk, Virginia, Forente stater, 23507
        • Sentara Norfolk General

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria

  1. Patient is located in a participating unit.
  2. Planned procedure is orotracheal intubation using a laryngoscope.
  3. Planned operator is a clinician expected to routinely perform tracheal intubation in the participating unit.

Exclusion Criteria:

  1. Patient is known to be less than 18 years old.
  2. Patient is known to be pregnant.
  3. Patient is known to be a prisoner.
  4. Immediate need for tracheal intubation precludes safe performance of study procedures.
  5. Operator has determined that use of a direct laryngoscope is required for the optimal care of the patient.
  6. Operator has determined that use of a hyperangulated video laryngoscope blade or a standard geometry video laryngoscope blade is required or contraindicated for the optimal care of the patient either because of factors related to the patient (e.g., patient's upper airway anatomy requires a specific blade type) or the operator (e.g., treating clinicians lack sufficient comfort with one of the blade types).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Hyperangulated video laryngoscope blade

For patients assigned to the hyperangulated video laryngoscope blade group, the operator will use a hyperangulated video laryngoscope blade on the first laryngoscopy attempt.

Hyperangulated video laryngoscope blade

Aktiv komparator: Standard Geometry Video Laryngoscope Blade Group

For patients assigned to the standard geometry laryngoscope blade group, the operator will use a standard geometry video laryngoscope blade on the first laryngoscopy attempt.

Standard geometry video laryngoscope blade

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Successful intubation on the first attempt.
Tidsramme: Duration of placement of the endotracheal tube, an average duration of two minutes.

Successful intubation on the first attempt is defined as placement of an endotracheal tube in the trachea with a single insertion of a laryngoscope blade into the mouth and EITHER a single insertion of an endotracheal tube into the mouth OR a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube over the bougie into the mouth.

Duration of placement of the endotracheal tube, an average duration of two minutes.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Hypoxemia
Tidsramme: During the interval between induction and 2 minutes after tracheal intubation.

The secondary outcome is hypoxemia, defined as a peripheral oxygen saturation < 85% during the interval between induction and 2 minutes after tracheal intubation.

During the interval between induction and 2 minutes after tracheal intubation.

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Antall laryngoskopiforsøk
Tidsramme: Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Antall bougieforsøk
Tidsramme: Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Antall forsøk på endotrakeal tube
Tidsramme: Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Øsofagusintubasjon
Tidsramme: Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Skade på tennene
Tidsramme: Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Operatørrapportert aspirasjon
Tidsramme: Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Varighet for plassering av endotrachealtuben, en gjennomsnittlig varighet på to minutter.
Død på sykehus innen 1 time
Tidsramme: 1 time
1 time
Død på sykehus innen 28 dager
Tidsramme: I de første 28 dagene etter påmelding
I de første 28 dagene etter påmelding
Ventilatorfrie dager gjennom dag 28
Tidsramme: I de første 28 dagene etter påmelding
I de første 28 dagene etter påmelding
ICU-frie dager gjennom dag 28
Tidsramme: I de første 28 dagene etter påmelding
I de første 28 dagene etter påmelding
Cormack-Lehane grade of glottic view
Tidsramme: Duration of placement of the endotracheal tube, an average duration of two minutes.

Cormack-Lehane grade of glottic view on the first laryngoscopy attempt

Duration of placement of the endotracheal tube, an average duration of two minutes.
Duration of intubation
Tidsramme: Duration of placement of the endotracheal tube, an average duration of two minutes.

The time (in seconds) between the initial insertion of the laryngoscope blade into the mouth and the final placement of an endotracheal tube or tracheostomy tube in the trachea.

Duration of placement of the endotracheal tube, an average duration of two minutes.
Severe complications during intubation
Tidsramme: Between induction and 2 minutes after intubation.

The development of one or more of the following between induction and 2 minutes after intubation: (1) severe hypoxemia (SpO2 <80%), (2) severe hypotension (systolic blood pressure <80 mm Hg or new or increased vasopressor administration), and (3) cardiac arrest.

Between induction and 2 minutes after intubation.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

30. desember 2025

Primær fullføring (Antatt)

1. april 2027

Studiet fullført (Antatt)

1. mai 2027

Datoer for studieregistrering

Først innsendt

30. oktober 2025

Først innsendt som oppfylte QC-kriteriene

30. oktober 2025

Først lagt ut (Faktiske)

3. november 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

21. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

16. september 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere